Trial intelligence / Profile preview

Phase III chemoradiation with tirapazamine + cisplatin vs cisplatin in advanced head and neck cancer

2004-002017-37Phase 3Completed

Sponsor
Sanofi
Start
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tirapazamine in head and neck squamous cell carcinoma (HNSCC), sponsored by Sanofi. Started Jan 2005; status: completed.

02

Drugs

tirapazamine
03

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on 2004-002017-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002017-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call